Polynucleotides & salmon DNA (PDRN): does it work?

Polynucleotides and PDRN are injectable "skin boosters" made from purified salmon DNA, and they have become one of the most talked-about regenerative treatments in aesthetics. The pitch is appealing: instead of plumping a wrinkle with filler, these products are supposed to help your own skin make more collagen and repair itself. The honest answer to "does it work" is more layered than the marketing. There is real biology behind these molecules and a small but growing pile of clinical studies, yet most of that research is low quality, much of it is industry-linked, and the strongest data comes from healing wounds rather than rejuvenating healthy faces.

What polynucleotides and PDRN actually are

Both polynucleotides (PN) and polydeoxyribonucleotide (PDRN) are fragments of DNA. The DNA is extracted from the gonadal tissue (sperm and roe) of salmon and trout, then heavily purified to strip out proteins that could trigger allergic reactions. What is left are chains of nucleotides — the building blocks of DNA — suspended in a gel or liquid.

The "salmon sperm" headline is technically accurate but misleading. The finished product contains no living cells, no salmon protein worth speaking of, and none of the fish's genetic instructions in any usable form. It is purified nucleic acid. Salmon and trout are used because their DNA is structurally similar to human DNA, abundant, and considered low-risk for cross-species immune reactions.

The two terms get used interchangeably in spas, but they are not the same molecule.

PN versus PDRN: the key difference

The main difference is the length of the DNA chains, measured by molecular weight in kilodaltons (kDa). A proposed cutoff in the scientific literature puts polynucleotides at roughly 1,500 kDa and above (long chains) and PDRN below 1,500 kDa (shorter chains). Longer is not automatically better — the two behave differently in the skin.

In practice, a clinic may use the words "polynucleotide," "PDRN," "salmon DNA," and a brand name like Rejuran or Plinest to describe what looks like the same syringe. They are related cousins, not identical twins, and the distinction matters when you read studies — most wound-healing data is PDRN, while most facial-rejuvenation data is PN. A 2025 comparison review in Pharmaceutics lays out these molecular and clinical differences in detail.

How they are supposed to work

There are two proposed mechanisms, and they are not equally well supported.

1. The biochemical signal (mainly PDRN). PDRN is thought to bind the adenosine A2A receptor on cells. Activating this receptor sets off a chain of events: it raises levels of a messenger molecule called cAMP, nudges fibroblasts (the cells that make collagen) to multiply, encourages the growth of tiny new blood vessels (angiogenesis), and dials down inflammation by quieting pro-inflammatory pathways. PDRN also feeds the "salvage pathway," recycling the nucleotides your cells need to build new DNA. This is the mechanism with the most laboratory backing, and it is genuinely interesting biology — but most of it was worked out in wounds, burns, and damaged tissue, not in healthy aging skin.

2. The physical scaffold (mainly PN). Long polynucleotide chains can form a gel-like, three-dimensional mesh in the dermis. This mesh holds water, which improves hydration and gives a temporary plumping effect, and it may act as a loose framework that supports fibroblasts as they remodel the surrounding tissue. This is less about pharmacology and more about giving the skin a scaffold to work with.

The catch: a mechanism that works beautifully in a test dish or a chronic ulcer does not guarantee a visible result on a 45-year-old's cheek. Lab plausibility is the beginning of the evidence chain, not the end of it. Many ingredients with elegant mechanisms — measurable in a petri dish, glowing in mouse studies — fail to produce a difference a human can see in a mirror. The history of skincare is littered with molecules that worked on paper and disappointed on faces. So while the A2A receptor story and the scaffold story are both biologically reasonable, "reasonable" is a long way from "proven on real patients."

A third, softer factor is worth naming honestly: the act of injecting anything into the skin causes a small controlled injury, and controlled injury alone (the same principle behind microneedling) triggers a wound-repair response that boosts collagen. Some of the glow people credit to salmon DNA may simply be the skin reacting to the needle. Without a proper control group that gets needled with an inert substance, it is impossible to separate the molecule's effect from the needle's effect — and most polynucleotide studies do not include that control.

The actual evidence, graded honestly

This is where careful reading matters, because the gap between the marketing and the published data is wide.

Skin rejuvenation: real but weak evidence

The most relevant document is a 2025 systematic review in the Journal of Cosmetic Dermatology by Lampridou and colleagues. It pooled nine clinical studies covering 219 patients who received polynucleotide treatment for skin rejuvenation. Across those studies, patients tended to show improvements in wrinkles, skin texture, and elasticity, with side effects that were mild and short-lived.

So far, so encouraging. But the same review is blunt about quality: the nine studies were of "low and moderate quality." That phrase is doing a lot of work. It means small patient numbers, short follow-up, frequent lack of blinding, and often no placebo or control group. When a study has no control arm, you cannot separate the treatment's effect from the natural placebo response, the moisturizing effect of any injection, or simple measurement bias from people who know they paid for a treatment and expect to look better.

A representative single study, the PN-HPT facial middle-third rejuvenation paper in the same journal, reported improvements in skin quality — but it is exactly the kind of small, open-label, industry-adjacent study that makes up the bulk of this field.

Wound healing: stronger, but a different question

PDRN has a much more solid evidence base for healing damaged tissue, and this is where it earned its medical reputation. A 2020 systematic review in Regenerative Medicine found consistent benefit for wound healing and tissue regeneration. PDRN has been studied in diabetic foot ulcers, where one study showed it improved peripheral tissue oxygenation and accelerated angiogenesis. A meta-analysis of randomized controlled trials even found PDRN effective and safe for knee osteoarthritis pain.

Here is the crucial caveat that the marketing skips: healing a chronic ulcer and rejuvenating healthy skin are not the same problem. A wound is inflamed, poorly oxygenated, and stuck in a broken repair cycle, and PDRN's job there is to restart a stalled process. Healthy aging skin is not broken in that way. Borrowing wound-healing data to support cosmetic claims is a scientific leap that has not been validated in large, well-controlled cosmetic trials.

Evidence summary

The pattern is consistent: the evidence is strongest exactly where these molecules are not being sold as beauty treatments, and weakest where they are most heavily marketed.

The industry-funding problem

A large share of polynucleotide research is conducted, funded, or co-authored by people connected to the companies that sell the products, or published in journals with a commercial aesthetics focus. That does not make the findings false, but it is a known source of bias that pushes results toward the positive. When you see a glowing study, check who paid for it and whether there was a real control group. Independent, large, blinded, placebo-controlled trials on healthy skin remain rare. Until those exist, treat strong rejuvenation claims with caution.

How a treatment is done

Polynucleotides and PDRN are almost always delivered by injection or needle-based methods, because the intact molecules are too large to cross the skin barrier in a meaningful amount when simply rubbed on.

A typical rejuvenation course is 2 to 4 sessions spaced about 2 to 4 weeks apart, sometimes followed by maintenance every few months. Topical "salmon DNA" serums and sheet masks exist and are sold widely, but the molecules in them mostly sit on the surface; there is little evidence that a cream delivers the deep-tissue effects studied with injections. If a product claims injection-level results from a jar, be skeptical.

What results to realistically expect

Set expectations low and you will rarely be disappointed. These are not fillers, so do not expect to see added volume or a wrinkle vanish on the table. The reported changes are gradual and subtle: skin that looks a little more hydrated, slightly smoother, with a softer "glow" that builds over the weeks after a course rather than appearing overnight. Most studies measure improvement over 8 to 12 weeks, and any benefit that does occur tends to fade over months without maintenance, because the product is metabolized and the skin's own aging continues.

In honest before-and-after terms: the changes are the kind you notice in good lighting and a mirror up close, not the kind that prompt friends to ask what you had done. People who want a dramatic, visible transformation are usually better served by treatments with a different mechanism and stronger evidence. People who want an incremental "skin quality" tune-up, and who understand the data is thin, are the better fit.

What it costs

Pricing varies widely by city and provider, but a single session commonly runs from a few hundred dollars into the low four figures, and most protocols call for several sessions plus maintenance. That adds up quickly. Because the evidence does not yet establish these injections as a must-have, the cost-to-proof ratio is unfavorable compared with cheaper, better-studied options. If budget is a real constraint, spending the same money on a dermatologist visit and a proven prescription retinoid will almost certainly do more for long-term collagen.

Safety: generally mild, with real caveats

The safety signal in the published studies is reassuring on its face. Reported side effects are usually mild and temporary: redness, swelling, bruising, tenderness, small lumps, and occasional itching at injection sites, typically resolving within days. True allergic reactions to the salmon DNA itself appear to be rare because of the purification, though anyone with a known fish allergy should flag it and proceed cautiously or avoid it.

The bigger safety issues are not about the molecule — they are about how and where it is administered:

• Injection risks are real. Any injectable carries a risk of infection, vascular occlusion (product blocking a blood vessel, which is rare but serious), and granulomas (lumps of inflammatory tissue).
• Product sourcing is a wild card. Because injectable PN and PDRN are not FDA-approved in the US, products used here are often imported. Sterility, concentration, and purity are not guaranteed by US regulators, so quality depends entirely on the supplier and the clinic.
• Operator skill matters more than the product. Most serious complications in aesthetics trace back to who is holding the needle, not the substance in the syringe.

The FDA's consumer guidance on injectable dermal fillers and soft-tissue fillers is worth reading before any needle-based aesthetic treatment, since the general cautions about provider qualifications and unapproved products apply directly here.

The US regulatory reality

This is the part most marketing leaves out, and it is important.

Injectable polynucleotides and PDRN are not FDA-approved in the United States. Products like Rejuran, Plinest, and Nucleofill are approved and widely used in South Korea, the UK, and parts of Europe and Asia, but they have not cleared the FDA's review process for injection in the US. The clearances that do exist in the US are generally for topical application paired with microneedling — not for injecting the product into the dermis.

What that means in plain terms:

• A US clinic injecting these products is using them off-label or with unapproved imported product.
• The product's sterility and contents are not guaranteed by the FDA.
• Marketing them as "FDA-approved injectables" is inaccurate.

If a US provider tells you their salmon-DNA injection is FDA-approved, that is a red flag worth questioning. Approved for topical microneedling is not the same as approved for injection. None of this means the products are unsafe — it means the usual US regulatory backstop is missing, so the burden of vetting the clinic and the source falls on you.

How it compares to the alternatives

Polynucleotides sit in the "regenerative" category — treatments meant to improve skin quality rather than just fill or freeze. Here is how the honest comparison shakes out.

The uncomfortable comparison: a daily prescription retinoid has far stronger, more independent evidence for building collagen than any salmon-DNA injection, and it costs a fraction as much. For an evidence-first reader, that context matters. Polynucleotides may add something on top of the basics, but they are not a replacement for proven fundamentals. If you want to dig into the science of how skin builds and loses collagen, our collagen science explainer covers the fundamentals, and our overview of spa treatments that actually work puts these newer options in context.

Who it might be for — and who should skip it

Reasonable candidates:

• People with dull, dehydrated, or early-aging skin who want overall "skin quality" improvement rather than volume.
• Those who have already nailed the basics (sun protection, retinoids) and want to layer on a regenerative option.
• Patients seeking a more natural look than fillers provide, who understand the evidence is preliminary.

Better off waiting or choosing something else:

• Anyone expecting dramatic, filler-like results — these are subtle treatments.
• People with a fish allergy (proceed only with caution and provider sign-off).
• Anyone who is pregnant or breastfeeding (untested; avoid).
• Bargain hunters — a multi-session course adds up, and the evidence does not yet justify it as a must-have.
• Anyone uncomfortable with off-label, non-FDA-approved injectables in the US.

If you are weighing this against other regenerative options, our comparison of exosome versus PRP facials and the broader regenerative aesthetics outlook are useful next reads.

The bottom line

Polynucleotides and PDRN are not snake oil — there is genuine biology here, and the wound-healing evidence for PDRN is real. But the case for injecting purified salmon DNA into healthy skin for anti-aging rests on small, low-quality, often industry-linked studies, and the strongest data comes from a different problem entirely. The treatments appear safe in trained hands, the side effects are usually mild, and many patients are happy. Just go in clear-eyed: this is a promising, under-proven treatment that is not FDA-approved for injection in the US, not a clinically validated miracle. Treat the marketing with the skepticism it has earned, vet your provider hard, and keep your expectations modest.

Frequently Asked Questions

Is salmon DNA the same as salmon sperm in these injections?

The DNA is extracted from salmon and trout reproductive tissue, including sperm and roe, then heavily purified. The finished product is purified nucleic acid — it contains no living cells, no functional fish genes, and almost no protein. The "salmon sperm facial" label is attention-grabbing but oversimplified.

Are polynucleotide or PDRN injections FDA-approved in the US?

No. Injectable polynucleotides and PDRN (including brands like Rejuran and Plinest) are not FDA-approved for injection in the United States. Some products have clearance only for topical use with microneedling. US injections use off-label or imported product, so quality and sterility are not FDA-guaranteed. Treatments are approved in countries like South Korea, the UK, and parts of Europe.

Does the evidence actually show they work for wrinkles?

The evidence is weak but not absent. A 2025 systematic review of nine studies and 219 patients reported improvements in wrinkles, texture, and elasticity, but graded the studies as low to moderate quality with frequent lack of controls. The wound-healing evidence for PDRN is much stronger, but that is a different use. For skin rejuvenation, call it promising, not proven.

What is the difference between PN and PDRN?

Both are salmon-derived DNA fragments, but PN (polynucleotide) has longer chains, roughly 1,500 kDa and above, while PDRN is shorter, below 1,500 kDa. PN acts more like a hydrating physical scaffold in the dermis; PDRN works more through adenosine A2A receptor signaling and is the better-studied molecule for wound healing.

Are these injections safe?

In published studies, side effects are usually mild and temporary: redness, swelling, bruising, and small lumps that resolve within days. The larger risks come from injection itself (infection, rare vascular events) and from unregulated imported product in the US. People with fish allergies should be cautious, and pregnant or breastfeeding people should avoid it. Provider skill and product sourcing matter more than the molecule.

References and sources

• Lampridou S, et al. The Effectiveness of Polynucleotides in Esthetic Medicine: A Systematic Review. Journal of Cosmetic Dermatology, 2025. (The 9-study, 219-patient review; explicitly grades the evidence as low to moderate quality.)
• Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives. Pharmaceutics, 2025. (Source for the PN vs PDRN molecular-weight distinction and mechanisms.)
• The effects of polydeoxyribonucleotide on wound healing and tissue regeneration: a systematic review. Regenerative Medicine, 2020. (The stronger wound-healing evidence base for PDRN.)
• Polydeoxyribonucleotide Improves Peripheral Tissue Oxygenation and Accelerates Angiogenesis in Diabetic Foot Ulcers. Archives of Plastic Surgery, 2017.
• The efficacy and safety of polydeoxyribonucleotide for the treatment of knee osteoarthritis: systematic review and meta-analysis of RCTs. Medicine, 2019. (Non-skin use with moderate evidence.)
• PN-HPT (Polynucleotides Highly Purified Technology) in facial middle third rejuvenation. Journal of Cosmetic Dermatology, 2022. (Representative single facial-rejuvenation study.)
• Regenerative Complex with Non-Cross-Linked Hyaluronic Acid and a High-Molecular-Weight Polynucleotide for Periorbital Treatment. Polymers, 2025.
• US FDA. Dermal Fillers (Soft Tissue Fillers) — consumer and provider guidance on injectable safety and approval status.
• Browse the wider literature: PubMed search for polynucleotide skin rejuvenation clinical studies and PubMed search for PDRN salmon DNA aesthetic safety.

This article is for general information only and is not medical advice. Talk to a qualified, licensed medical professional before starting any aesthetic or medical treatment.